Current Roles

Employees:
148
Revenue:
$28.7M
About
Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs. Our platform enables us to discover peptides in a de novo fashion with the desired degree of potency, specificity and selectivity, and also engineer oral stability with specific peptidomimetic and chemical modifications. We have successfully utilized this platform to discover PN-943 and PTG-200 which are oral, GI-restricted peptides for inflammatory bowel diseases (IBD), as well as PTG-300, an injectable peptide for rare blood disorders.
Protagonist Therapeutics Address
7707 Gateway Boulevard
Newark, null
Protagonist Therapeutics Email
Protagonist Therapeutics Phone Numbers
510-474-0170

Past Companies

Protagonist TherapeuticsDirector
Protagonist TherapeuticsAssociate Director
Protagonist TherapeuticsSenior Scientist II

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.